Cancer chemopreventive effects of lactic acid bacteria

Journal of Microbiology and Biotechnology

Volumn 17, Issue 8, 2007, Pages 1227-1235

  Kim, Jong Eun ^a   Kim, Ji Yeon ^b   Lee, Ki Won ^c   Lee, Hyong Joo ^a  

^a Seoul National University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Cancer; Chemoprevention; Lactic acid bacteria

Indexed keywords

CHOLESTEROL;

ANTIOXIDANT ACTIVITY; BLADDER CANCER; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COLON CANCER; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LACTIC ACID BACTERIUM; LIVER CANCER; NONHUMAN; NUTRITIONAL VALUE; REVIEW; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; BIFIDOBACTERIUM; FEMALE; HUMANS; LACTOCOCCUS; MALE; NEOPLASMS;

EID: 34548487173     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Agha-Mohammadi, S. and M. T. Lotze. 2000. Immunomodulation of cancer: Potential use of selectively replicating agents. J. Clin. Invest. 105: 1173-1176.
2. Aso, Y. and H. Akazan. 1992. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol. Int. 49: 125-129.
3. Bae, E. A., D. H. Kim, and M. J. Han. 2000. Anti-Helicobacter pylori activity of Bifidobacterium spp. J Microbiol. Biotechnol. 10: 532-534.
4. Bae, J. M., K. W. Jung, and Y. J. Won. 2002. Estimation of cancer deaths in Korea for the upcoming years. J. Korean Med. Sci. 17: 611-615.
5. Baricault, L., G. Denariaz, J. J. Houri, C. Bouley, C. Sapin, and G. Trugnan. 1995. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16: 245-252.
6. Biffi, A., D. Coradini, R. Larsen, L. Riva, and G. Di Fronzo. 1997. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 28: 93-99.
7. Burns, A. J. and I. R. Rowland. 2004. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 551: 233-243.
8. Cerutti, P. A. 1985. Prooxidant states and tumor promotion. Science 227: 375-381.
9. Chang, H. C., Y. D. Choi, and H. J. Lee. 1996. Molecular cloning of a β-D-galactosidase gene from Lactococcus lactis subsp. lactis 7962. J. Microbiol. Biotechnol. 6: 386-390.
10. Chang, J. H., J. H. Shin, I. S. Chung, and H. J. Lee. 1999. Improved menthol production using suspension cultures of Mentha piperita with pectinase elicitation. J. Microbiol. Biotechnol. 9: 358-360.
11. Choi, S. S., Y. Kim, K. S. Han, S. You, S. Oh, and S. H. Kim. 2006. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett. Appl. Microbiol. 42: 452-458.
12. Clausen, M. R. and P. B. Mortensen. 1997. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53: 930-942.
13. de Moreno de LeBlanc, A., C. Matar, N. LeBlanc, and G. Perdigon. 2005. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 7: R477-R486.
14. El-Nezami, H. S., N. N. Polychronaki, J. Ma, H. Zhu, W. Ling, E. K. Salminen, R. O. Juvonen, S. J. Salminen, T. Poussa, and H. M. Mykkanen. 2006. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am. J. Clin. Nutr. 83: 1199-1203.
15. Felley, C. and P. Michetti. 2003. Probiotics and Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 17: 785-791.
16. Fujino, T. 2001. The tumor-preventing effect of a mixture of several lactic acid bacteria on 1,2-dimethylhydrazine-induced colon carcinogenesis in mice. Oncol. Rep. 8: 1073-1078.
17. Gibson, G. R. and R. Fuller. 2000. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J. Nutr. 130: 391S-395S.
18. Gilliland, S. E. 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 7: 175-188.
19. Goldin, B. and S. L. Gorbach. 1977. Alterations in fecal microflora enzymes related to diet, age, Lactobacillus supplements, and dimethylhydrazine. Cancer 40: 2421-2426.
20. Goldin, B. R. and S. L. Gorbach. 1980. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J. Natl. Cancer Inst. 64: 263-265.
21. Goldin, B. R. and S. L. Gorbach. 1984. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr. 39: 756-761.
22. Gotteland, M. and S. Cruchet. 2003. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J. Antimicrob. Chemother. 51: 1317-1319.
23. Guarner, F. and J.-R. Malagelada. 2003. Gut flora in health and disease. Lancet 361: 512-519.
24. Halliwell, B. 2007. Oxidative stress and cancer: Have we moved forward? Biochem. J. 401: 1-11.
25. Han, S. Y., C. S. Huh, Y. T. Ahn, K. S. Lim, Y. J. Baek, and D. H. Kim. 2005. Hepatoprotective effect of lactic acid bacteria, inhibitors of beta-glucuronidase production against intestinal microflora. Arch. Pharm. Res. 28: 325-329.
26. Hanahan, D. and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57-70.
27. Hur, H. J., K. W. Lee, H. Y. Kim, D. K. Chung, and H. J. Lee. 2006. In vitro immunopotentiating activities of cellular fractions of lactic acid bacteria isolated from kimchi and Bifidobacteria. J. Microbiol. Biotechnol. 16: 661-666.
28. Hur, H. J., K. W. Lee, and H. J. Lee. 2004. Production of nitric oxide, tumor necrosis factor-alpha and interleukin-6 by RAW264.7 macrophage cells treated with lactic acid bacteria isolated from kimchi. Biofactors 21: 123-125.
29. Ishikawa, H., I. Akedo, T. Otani, T. Suzuki, T. Nakamura, I. Takeyama, S. Ishiguro, E. Miyaoka, T. Sobue, and T. Kakizoe. 2005. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116: 762-767.
30. Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun. 2007. Cancer statistics, 2007. CA Cancer J. Clin. 57: 43-66.
31. Kabir, A. M., Y. Aiba, A. Takagi, S. Kamiya, T. Miwa, and Y. Koga. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41: 49-55.
32. Kaizu, H., M. Sasaki, H. Nakajima, and Y. Suzuki. 1993. Effect of antioxidative lactic acid bacteria on rats fed a diet deficient in vitamin E. J. Dairy Sci. 76: 2493-2499.
33. Kato, I., T. Yokokura, and M. Mutai. 1988. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice. Cancer-Immunol. Immunother. 26: 215-221.
34. Kato, I., T. Yokokura, and M. Mutai. 1983. Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol. 27: 611-618.
35. Kim, D. W., Y. J. Bang, D. S. Heo, and N. K. Kim. 2002. Colorectal cancer in Korea: Characteristics and trends. Tumori 88: 262-265.
36. Kim, J. E., D. W. Jeong, and H. J. Lee. 2007. Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr. Purif. 53: 9-15.
37. Kim, J. Y., S. Lee, D. W. Jeong, S. Hachimura, S. Kaminogawa, and H. J. Lee. 2005. Effects of intraperitoneal administration of Lactococcus lactis ssp. lactis cellular fraction on immune response. Food Sci. Biotechnol. 14: 405-409.
38. Kim, J. Y., S. Lee, D. W. Jeong, S. Hachimura, S. Kaminogawa, and H. J. Lee. 2006. In vivo immunopotentiating effects of cellular components from Lactococcus lactis ssp. lactis. J Microbiol. Biotechnol. 16: 786-790.
39. Kim, J. Y., H. J. Woo, Y. S. Kim, K. H. Kim, and H. J. Lee. 2003. Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp. lactis in SNUC2A, a colon cancer cell line. Nutr. Cancer 46: 197-201.
40. Kim, J. Y., H. J. Woo, Y. S. Kim, and H. J. Lee. 2002. Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines. Biotechnol. Lett. 24: 1431-1436.
41. Kim, S. Y., K. W. Lee, J. Y. Kim, and H. J. Lee. 2004. Cytoplasmic fraction of Lactococcus lactis ssp. lactis induces apoptosis in SNU-1 stomach adenocarcinoma cells. Biofactors 22: 119-122.
42. Kim, T. S., J. W. Hur, M. A. Yu, C. I. Cheigh, K. N. Kim, J. K. Hwang, and Y. R. Pyun. 2003. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J. Food Prot. 66: 3-12.
43. Kim, Y., J. Y. Choi, K. M. Lee, S. K. Park, S. H. Ahn, D. Y. Noh, Y. C. Hong, D. Kang, and K. Y. Yoo. 2007. Dose-dependent protective effect of breast-feeding against breast cancer among ever-lactated women in Korea. Eur. J. Cancer Prev. 16: 124-129.
44. Kubota, Y. 1990. Fecal intestinal flora in patients with colon adenoma and colon cancer. Nippon Shokakibyo Gakkai Zasshi 87: 771-779.
45. Kulkarni, N. and B. S. Reddy. 1994. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc. Soc. Exp. Biol. Med. 207: 278-283.
46. Lankaputhra, W. E. and N. P. Shah. 1998. Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res. 397: 169-182.
47. Lee, H. M. and Y. Lee. 2006. Isolation of Lactobacillus plantarum from kimchi and its inhibitory activity on the adherence and growth of Helicobacter pylori. J. Microbiol. Biotechnol. 16: 1513-1517.
48. Lee, J. E., G. J. Woo, and H. J. Lee. 1996. Tetramethylpyrazine production by immobilized culture of Lactococcus lactis subsp. lactis biovar diacetilactis FC1. J Microbiol. Biotechnol. 6: 137-141.
49. Lee, J. M., J. Y. Choi, J. H. Lee, H. C. Chang, D. K. Chung, J. H. Kim, and H. J. Lee. 1999. Cloning and expression of the UDP-galactose-4-epimerase gene (galE) constituting the gal/lac operon of Lactococcus lactis ssp. lactis ATCC7962. J Microbiol. Biotechnol. 9: 393-397.
50. Lee, J. W., J. G. Shin, E. H. Kim, H. E. Kang, I. B. Yim, J. Y. Kim, H. G. Joo, and H. J. Woo. 2004. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J. Vet. Sci. 5: 41-48.
51. Lee, K. H., J. Y. Park, S. J. Jeong, G. H. Kwon, H. J. Lee, H. C. Chang, D. K. Chung, J. H. Lee, and J. H. Kim. 2007. Characterization of paraplantaricin C7, a novel bacteriocin produced by Lactobacillus paraplantarum C7 isolated from kimchi. J. Microbiol. Biotechnol. 17: 287-296.
52. Lee, K. W. and H. J. Lee. 2006. The roles of polyphenols in cancer chemoprevention. Biofactors 26: 105-121.
53. Lee, K. W., H. J. Lee, H. Y. Cho, and Y. J. Kim. 2005. Role of the conjugated linoleic acid in the prevention of cancer. Crit. Rev. Food Sci. Nutr. 45: 135-144.
54. Lim, B. K., R. Mahendran, Y. K. Lee, and B. H. Bay. 2002. Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn. J. Cancer Res. 93: 36-41.
55. Lin, D. C. 2003. Probiotics as functional foods. Nutr. Clin. Pract. 18: 497-506.
56. Lin, M. Y. and F. J. Chang. 2000. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci. 45: 1617-1622.
57. Lin, M. Y. and C. L. Yen. 1999. Antioxidative ability of lactic acid bacteria. J. Agric. Food Chem. 47: 1460-1466.
58. Lin, M. Y. and C. L. Yen. 1999. Inhibition of lipid peroxidation by Lactobacillus acidophilus and Bifidobacterium longum. J. Agric. Food Chem. 47: 3661-3664.
59. Lorca, G. L., T. Wadstrom, G. F. Valdez, and A. Ljungh. 2001. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol. 42: 39-44.
60. Matsuzaki, T. 1998. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41: 133-140.
61. Nanji, A. A., U. Khettry, and S. M. Sadrzadeh. 1994. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205: 243-247.
62. Oberfield, R. A., G. Steele Jr., J. L. Gollan, and D. Sherman. 1989. Liver cancer. CA Cancer J. Clin. 39: 206-218.
63. Ohashi, Y., S. Nakai, T. Tsukamoto, N. Masumori, H. Akaza, N. Miyanaga, T. Kitamura, K. Kawabe, T. Kotake, M. Kuroda, S. Naito, H. Koga, Y. Saito, K. Nomata, M. Kitagawa, and Y. Aso. 2002. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol. Int. 68: 273-280.
64. Orrhage, K., E. Sillerstrom, J. A. Gustafsson, C. E. Nord, and J. Rafter. 1994. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 311: 239-248.
65. Park, A., A. Rae-Jun, K. H. Lee, S. J. Kim, J. Y. Park, S. J. Nam, H. D. Yun, H. J. Lee, H. C. Chang, D. K. Chung, J. H. Lee, Y. H. Park, and J. H. Kim. 2002. Isolation of Lactococcus lactis strain with β-galactosidase activity from kimchi and cloning of lacZ gene from the isolated strain. J Microbiol. Biotechnol. 12: 157-161.
66. Park, I. S., Y. C. Lee, H. J. Park, T. I. Kim, S. I. Lee, H. Kim, K. S. Chung, and Y. C. Lee-Kim. 2001. Helicobacter pylori infection in Korea. Yonsei Med. J. 42: 457-470.
67. Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241.
68. Peek, R. M. Jr. and M. J. Blaser. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2: 28-37.
69. Perdigon, G., M. E. de Macias, S. Alvarez, G. Oliver, and A. A. de Ruiz Holgado. 1986. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53: 404-410.
70. Perdigon, G., M. E. Nader de Macias, S. Alvarez, G. Oliver, and A. A. Pesce de Ruiz Holgado. 1987. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. J. Dairy Sci. 70: 919-926.
71. Pool-Zobel, B. L., B. Bertram, M. Knoll, R. Lambertz, C. Neudecker, U. Schillinger, P. Schmezer, and W. H. Holzapfel. 1993. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr. Cancer 20: 271-281.
72. Rafter, J., M. Bennett, G. Caderni, Y. Clune, R. Hughes, P. C. Karlsson, A. Klinder, M. O'Riordan, G. C. O'Sullivan, B. Pool-Zobel, G. Rechkenimer, M. Roller, I. Rowland, M. Salvadori, H. Thijs, J. Van Loo, B. Watzl, and J. K. Collins. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85: 488-496.
73. Reddy, B. S. and A. Rivenson. 1993. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res. 53: 3914-3918.
74. Rokka, S., A. Pihlanto, H. Korhonen, and V. Joutsjoki. 2006. In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett. Appl. Microbiol. 43: 508-513.
75. Rowland, I. R., C. J. Rumney, J. T. Coutts, and L. C. Lievense. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19: 281-285.
76. Saito, H., H. Tomioka, and K. Nagashima. 1987. Protective and therapeutic efficacy of Lactobacillus casei against experimental murine infections due to Mycobacterium fortuitum complex. J. Gen. Microbiol. 133: 2843-2851.
77. Sekine, K., T. Kawashima, and Y. Hashimoto. 1994. Comparison of the TNF-α levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora 13: 79-89.
78. Sellers, W. R. and D. E. Fisher. 1999. Apoptosis and cancer drug targeting. J. Clin. Invest. 104: 1655-1661.
79. Sengupta, N., E. Siddiqui, and F. H. Mumtaz. 2004. Cancers of the bladder. J. R. Soc. Health 124: 228-229.
80. Seow, S. W., J. N. B. Rahmat, A. A. K. Mohamed, R. Mahendran, Y. K. Lee, and B. H. Bay. 2002. Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (Bacillus Calmette-Guerin). J. Urol. 168: 2236-2239.
81. Sgouras, D., P. Maragkoudakis, K. Petraki, B. Martinez-Gonzalez, E. Eriotou, S. Michopoulos, G. Kalantzopoulos, E. Tsakalidou, and A. Mentis. 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70: 518-526.
82. Singh, J., A. Rivenson, M. Tomita, S. Shimamura, N. Ishibashi, and B. S. Reddy. 1997. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18: 833-841.
83. Sporn, M. B. and N. Sub. 2000. Chemoprevention of cancer. Carcinogenesis 21: 525-530.
84. Stiles, M. E. and W. H. Holzapfel. 1997. Lactic acid bacteria of foods and their current taxonomy. Int. J. Food Microbiol. 36: 1-29.
85. Surh, Y. J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768-780.
86. Teitelbaum, J. E. and W. A. Walker. 2002. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22: 107-138.
87. Tolley, D. A., M. K. B. Parmar, K. M. Grigor, and G. Lallemand. 1996. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of followup. J. Urol. 155: 1233-1238.
88. van't Veer, P., J. M. Dekker, J. W. Lamers, F. J. Kok, E. G. Schouten, H. A. Brants, F. Sturmans, and R. J. Hermus. 1989. Consumption of fermented milk products and breast cancer: A case-control study in The Netherlands. Cancer Res. 49: 4020-4023.
89. Vanderhoof, J. A. and R. J. Young. 1998. Use of probiotics in childhood gastrointestinal disorders. J. Pediatr. Gastroenterol. Nutr. 27: 323-332.
90. Yasui, H., K. Shida, T. Matsuzaki, and T. Yokokura. 1999. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 76: 383-389.
91. Yasutake, N., T. Matsuzaki, K. Kimura, S. Hashimoto, T. Yokokura, and Y. Yoshikai. 1999. The role of tumor necrosis factor (TNF)-alpha in the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice. Med. Microbiol. Immunol. 188: 9-14.
92. Zhang, X. B. and Y. Ohta. 1991. Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J. Dairy Sci. 74: 1477-1481.